Adial Pharmaceuticals (ADIL) Q2 2026 Earnings

11MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-3.5
-2.39
-1.29
-0.18

Details

Expected EPS
-2.73
Actual EPS
-1.48
Surprise EPS
1.25
Surprise Percent
+45.79%

Description

Adial Pharmaceuticals (ADIL) has reported earnings of -1.48 per share for Q2 2026.

0 Comments

Share your thoughts